Device Trial Radar · NCT02655887
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
Last checked: Nov 20, 2026Latest source record: Feb 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
170
Actual
Start
Jun 15, 2016
Primary completion
Jun 19, 2018
Study completion Oct 30, 2020
Sponsor
- Lead sponsor
- C. R. BardPublic (BDX)
- Sponsor type
- Industry
- First posted
- Jan 14, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The BARD® Venovo™ Venous Stent Study is a non-randomized clinical study intended to collect confirmatory evidence of the safety and effectiveness of the Venous Stent for the treatment of iliofemoral occlusive disease.
Conditions
- May-Thurner Syndrome
- Peripheral Vascular Disease
- Venous Disease
- Iliofemoral Occlusive Disease
Interventions
VENOVO™ Venous StentDevice
VENOVO™ Venous stent placement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Primary Patency of the Venous Stent at 12 Months Post-Index ProcedureTime frame: 12 months post-index procedure
1 more outcomes with a free account
Locations
21 sites in 7 countries. Site status is shown where the registry gives one.
Vascular Breakthroughs, LLC
Darien, Connecticut
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.